Neurogene (NGNE) Earnings Date & Reports

Neurogene Inc is a clinical-stage biotechnology company committed to overcoming the limitations of neurological diseases into treatable conditions, by harnessing its proprietary transgene regulation technology, EXACT(Expression Attenuation via Construct Tuning)... Show more

Get AI intraday signals

A.I. Advisor

published Earnings

NGNE is expected to report earnings to -139 cents per share on August 07

Q2'26

Est.

$-1.40

Q1'26

Missed

by $0.12

Q4'25

Beat

by $0.13

Q3'25

Beat

by $0.19

Q2'25

Beat

by $0.06

The last earnings report on May 12 showed earnings per share of -138 cents, missing the estimate of -126 cents. With 23.98K shares outstanding, the current market capitalization sits at 508.82M.

View a ticker or compare two or three

Compare

NGNE

Setup

Daily Signal:

Description

Gain/Loss:

Interact to see
Advertisement

A.I.Advisor

published price charts

Last 5 trading days

View AI-Driven Trading for NGNE